The researchers wanted to determine the value of LDL-C as a risk biomarker for coronary heart disease, atherosclerotic cardiovascular disease, and stroke events and deaths for people stratified by age.
Neurology Advisor spoke with Dr Tom Yao, Neurosurgeon at Norton Health and Johnson & Johnson consultant, regarding the CERONEVUS study and the future prospects of stroke research.
Investigators analyzed mortality and clinical, laboratory, and echocardiography parameters possibly impacting health outcomes in BCPE vs BCNE.
Experts in infectious disease, pulmonology, cardiology, neurology, and psychiatry share their perspectives on the phenomenon that is long COVID-19.
Researchers aimed to study the associations between heart failure medications and certain systemic autoimmune rheumatic diseases.
Cardiologists around the world report experiencing harassment and discrimination in the workplace.
The association between stroke and obesity in adolescence was examined in a population-based study.
The American Heart Association and the American College of Cardiology believe there is “no better time to review and take a fresh perspective on medical ethics and professionalism in the light of established norms and current stressors.”
As acute ischemic stroke (AIS) is a known neurologic complication in patients with COVID-19, researchers sought to evaluate AIS in the convalescent phase of infection in younger adults.
The purpose of this update was to examine interval evidence of the acceptance and impact of the 2007 recommendations on viridans group streptococcal infective endocarditis and to make any necessary revisions based on this evidence.
